You are here: vision-research.eu » News

News

High-tech contact lenses are straight out of science fiction—and may replace smart phones

Over the years, new scientific discoveries have led to softer and more comfortable contact lenses. And now, research bringing together chemistry, biology and microelectronics is resulting in contact lenses that are straight out of science fiction.

The Children’s Eye Foundation of AAPOS Debuts “THE CURIOUS EYE” Interactive Storybook

The Children’s Eye Foundation of AAPOS unveiled the world’s first interactive children’s book to help screen for color vision deficiency (CVD), commonly known as color blindness. The foundation has posted a free digital version of THE CURIOUS EYE at thecuriouseye.org and published a first-run, hardcover book for its member pediatric ophthalmologists.

Advanced computer model could lead to improvements in 'bionic eye' technology

There are millions of people who face the loss of their eyesight from degenerative eye diseases. The genetic disorder retinitis pigmentosa alone affects 1 in 4,000 people worldwide.

Checklists work to improve science

Nature authors say a reproducibility checklist is a step in the right direction, but more needs to be done.

Commission appoints two new members to the Group of Chief Scientific Advisors to the European Commission

Commissioner Gabriel appointed two new members to the European Commission’s Group of Chief Scientific Advisors (GCSA) for the next three years.

Minimally invasive retinal reattachment procedure leads to superior photoreceptor integrity

A minimally invasive retinal reattachment procedure that can be done in an ophthalmologist's office leads to better long-term integrity and structure of the retina's photoreceptors—cells that allow us to see—compared with more invasive operating room procedures, according to new research

Oxford Finance Provides $125 Million Credit Facility to Kala Pharmaceuticals

Oxford Finance has announced the closing of a $125 million senior secured term loan with Kala Pharmaceuticals. Proceeds from the transaction will be used to refinance existing indebtedness and provide additional growth capital for the company’s marketing of its two approved ophthalmic products.

'Ice cube tray' scaffold is next step in returning sight to injured retinas

Tens of millions of people worldwide are affected by diseases like macular degeneration or have had accidents that permanently damage the light-sensitive photoreceptors within their retinas that enable vision.

Statement by the EIC Advisory Board and the ERC Scientific Council

The importance of knowledge creation and research for our well-being and the prosperity of our society and economies cannot be overstated. The ability to formulate questions and to seek answers to understand the world around us is a distinguishing feature of being human.

Gene therapy for common forms of congenital blindness shows promise to improve vision

A new gene therapy for one of the most common forms of congenital blindness was safe and improved patients' vision, according to initial data from a clinical trial led by researchers at the Scheie Eye Institute in the Perelman School of Medicine at the University of Pennsylvania.

Researchers grow stem cells to cure glaucoma

A joint research effort carried out by MIPT scientists and Harvard researchers has yielded retinal cells that can integrate into the retina.

Nanoscope presents optical gene delivery

Nanoscope Technologies LLC, a biotechnology company developing gene therapies for treatment of retinal diseases, is featuring multiple scientific presentations highlighting its groundbreaking research on optical gene delivery for vision restoration and OCT-guided electrophysiology platforms for characterization of retinal degeneration and assessment of efficacy of cell-gene therapy at the 2021 ARVO annual meeting

Glaukos Expands its Preserflo MicroShunt Relationship With Santen via New License Agreement

Glaukos announced that it has entered into a new development and commercialization license agreement with Santen Pharmaceutical for the Preserflo MicroShunt (development code: DE-128), superseding the previous collaboration and distribution agreements between the two parties.

Good research begins long before papers get written

Publishers are redoubling their commitment to transparency and reproducibility — but they can’t bring about change alone.

‘Hybrid’ scientific conferences aim to offer the best of in-person and virtual meetings

Last year, the COVID-19 pandemic upended the conference experience for researchers around the globe as scientific societies canceled in-person meetings and scrambled to hold virtual events in their place—with varying success.